Danaher, a global leader in life sciences and diagnostics innovation, plays a pivotal role in addressing some of the world's most pressing health challenges. Founded in 1984 by Steven and Mitchell Rales, the company is committed to continuous improvement and customer satisfaction, striving to enhance the quality of life for billions today while laying the groundwork for a healthier, more sustainable future.
Danaher's businesses span Biotechnology, Diagnostics, and Life Sciences, each dedicated to advancing healthcare solutions and improving patient outcomes worldwide. Within the Biotechnology sector, Cytiva stands out as a leading provider of technologies, services, and expertise crucial for the development, manufacturing, and delivery of therapeutics. Their innovations support the safe and efficient production of life-saving vaccines, biologic drugs, and novel cell and gene therapies.
In Diagnostics, Danaher's businesses are at the forefront of shaping the future of healthcare with cutting-edge point-of-care and laboratory solutions. They prioritize quality, productivity, automation, and scalability to drive improvements in patient care on a global scale.
Meanwhile, the Life Sciences division focuses on creating tools and technologies that drive breakthrough innovations in human health. Whether it's developing cutting-edge therapies or advancing pharmaceuticals and biopharmaceuticals, Danaher remains dedicated to advancing healthcare worldwide.